Kilitch Drugs (India) Limited

Equities

KILITCH

INE729D01010

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:50 2024-04-26 am EDT 5-day change 1st Jan Change
358.6 INR +2.15% Intraday chart for Kilitch Drugs (India) Limited +3.43% -3.54%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Kilitch Drugs (India) Unit Bags Supply Contract from Ethiopia MT
Kilitch Drugs Limited Wins Tender Issued by the Federal Democratic Republic of Ethiopia Pharmaceutical Supply Service for Supply of Pharmaceuticals CI
Kilitch Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Kilitch Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Kilitch Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Kilitch Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Kilitch Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Kilitch Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Kilitch Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Kilitch Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Kilitch Drugs Limited Announces Management Changes CI
Kilitch Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Kilitch Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Bhavin Mehta completed the acquisition of 7.13% of stake in Kilitch Drugs Limited from Mukund Mehta. CI
Kilitch Drugs Limited Announces Resignation of Princy Asati as Company Secretary & Compliance Officer CI
Bhavin Mehta agreed to acquire 7.13% of stake in Kilitch Drugs Limited from Mukund Mehta. CI
Kilitch Drugs Limited Commences New Facility Expansion Plan CI
Kilitch Drugs (India) to Build Pharma Complex in Khopoli, India MT
Kilitch Drugs Limited Announces Expansion of Manufacturing Facility at Khopoli CI
Kilitch Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Kilitch Drugs Limited announced that it expects to receive INR 22.14375 million in funding CI
Kilitch Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Kilitch Drugs Limited Announces Executive Changes CI
Kilitch Drugs India Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Kilitch Drugs India : Dugs (India) Starts Cephalosporin Injectables Production in Ethiopia MT
Chart Kilitch Drugs (India) Limited
More charts
Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in developing, manufacturing and marketing a range of pharmaceutical formulations. The Company’s products include Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. Its Parenteral and Nasal Products has a range of products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostic, uterine stimulants, veterinary and other areas in the form of ampoules and vials. Its range of oral formulations includes tablets, capsules, dry syrups and oral powders. It provides a range of cosmetics ranging from oil, lotion, liquid to cream and paste in the skin care, personal care and hair care categories. Its herbal products are useful for sore throat, prostate problems, and can be used as supplements for diabetes, obesity, libido and others. Its medical devices offer a C-Seal brand.
More about the company
  1. Stock Market
  2. Equities
  3. KILITCH Stock
  4. News Kilitch Drugs (India) Limited
  5. Kilitch Drugs India : Dugs (India) Starts Cephalosporin Injectables Production in Ethiopia